A private equity firm’s bid to combine the two biggest makers of medical-device coatings would harm competition for life-saving technologies, the Federal Trade Commission said at the start of a trial to block the deal. Combining the manufacturers of so-called hydrophilic — or water-loving — coatings would give Chicago-based private equity firm GTCRa 60% share of the market, FTC lawyer Maia Perez said during opening statements. The FTC is seeking to persuade a federal judge to halt GTCR’s purchase of Surmodics Inc.
Read the full article: GTCR-Surmodics Would Harm Medical Device Market, FTC Says //
Source: https://news.bloomberglaw.com/health-law-and-business/gtcrs-surmodics-buy-would-harm-medical-device-market-ftc-says